Cargando…

Sphingolipids in neurodegenerative diseases

Neurodegenerative Diseases (NDDs) are a group of disorders that cause progressive deficits of neuronal function. Recent evidence argues that sphingolipid metabolism is affected in a surprisingly broad set of NDDs. These include some lysosomal storage diseases (LSDs), hereditary sensory and autonomou...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Xueyang, Dutta, Debdeep, Lu, Shenzhao, Bellen, Hugo J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978793/
https://www.ncbi.nlm.nih.gov/pubmed/36875645
http://dx.doi.org/10.3389/fnins.2023.1137893
_version_ 1784899595929649152
author Pan, Xueyang
Dutta, Debdeep
Lu, Shenzhao
Bellen, Hugo J.
author_facet Pan, Xueyang
Dutta, Debdeep
Lu, Shenzhao
Bellen, Hugo J.
author_sort Pan, Xueyang
collection PubMed
description Neurodegenerative Diseases (NDDs) are a group of disorders that cause progressive deficits of neuronal function. Recent evidence argues that sphingolipid metabolism is affected in a surprisingly broad set of NDDs. These include some lysosomal storage diseases (LSDs), hereditary sensory and autonomous neuropathy (HSAN), hereditary spastic paraplegia (HSP), infantile neuroaxonal dystrophy (INAD), Friedreich’s ataxia (FRDA), as well as some forms of amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD). Many of these diseases have been modeled in Drosophila melanogaster and are associated with elevated levels of ceramides. Similar changes have also been reported in vertebrate cells and mouse models. Here, we summarize studies using fly models and/or patient samples which demonstrate the nature of the defects in sphingolipid metabolism, the organelles that are implicated, the cell types that are initially affected, and potential therapeutics for these diseases.
format Online
Article
Text
id pubmed-9978793
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99787932023-03-03 Sphingolipids in neurodegenerative diseases Pan, Xueyang Dutta, Debdeep Lu, Shenzhao Bellen, Hugo J. Front Neurosci Neuroscience Neurodegenerative Diseases (NDDs) are a group of disorders that cause progressive deficits of neuronal function. Recent evidence argues that sphingolipid metabolism is affected in a surprisingly broad set of NDDs. These include some lysosomal storage diseases (LSDs), hereditary sensory and autonomous neuropathy (HSAN), hereditary spastic paraplegia (HSP), infantile neuroaxonal dystrophy (INAD), Friedreich’s ataxia (FRDA), as well as some forms of amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD). Many of these diseases have been modeled in Drosophila melanogaster and are associated with elevated levels of ceramides. Similar changes have also been reported in vertebrate cells and mouse models. Here, we summarize studies using fly models and/or patient samples which demonstrate the nature of the defects in sphingolipid metabolism, the organelles that are implicated, the cell types that are initially affected, and potential therapeutics for these diseases. Frontiers Media S.A. 2023-02-16 /pmc/articles/PMC9978793/ /pubmed/36875645 http://dx.doi.org/10.3389/fnins.2023.1137893 Text en Copyright © 2023 Pan, Dutta, Lu and Bellen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Pan, Xueyang
Dutta, Debdeep
Lu, Shenzhao
Bellen, Hugo J.
Sphingolipids in neurodegenerative diseases
title Sphingolipids in neurodegenerative diseases
title_full Sphingolipids in neurodegenerative diseases
title_fullStr Sphingolipids in neurodegenerative diseases
title_full_unstemmed Sphingolipids in neurodegenerative diseases
title_short Sphingolipids in neurodegenerative diseases
title_sort sphingolipids in neurodegenerative diseases
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978793/
https://www.ncbi.nlm.nih.gov/pubmed/36875645
http://dx.doi.org/10.3389/fnins.2023.1137893
work_keys_str_mv AT panxueyang sphingolipidsinneurodegenerativediseases
AT duttadebdeep sphingolipidsinneurodegenerativediseases
AT lushenzhao sphingolipidsinneurodegenerativediseases
AT bellenhugoj sphingolipidsinneurodegenerativediseases